EFFECTS OF TARANABANT, A NOVEL CANNABINOID 1 RECEPTOR (CB-1R) INVERSE AGONIST, ON WEIGHT REDUCTION IN OBESE PATIENTS OVER 12 WEEKS
Carr R, Erondu N, Gonzalez C, Gumbiner B, Musser B, Lu K, Capece R, Klein S, Ravussin E, Amatruda J, Heymsfield S. EFFECTS OF TARANABANT, A NOVEL CANNABINOID 1 RECEPTOR (CB-1R) INVERSE AGONIST, ON WEIGHT REDUCTION IN OBESE PATIENTS OVER 12 WEEKS. Atherosclerosis Plus 2008, 9: 209. DOI: 10.1016/s1567-5688(08)70835-3.Peer-Reviewed Original Research
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply